Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 13/20 | 0.52 |
| ▸ | PDE4A | P27815 | 4/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 4/20 | 0.37 |
| ▸ | PDE4C | Q08493 | 4/20 | 0.37 |
| ▸ | PDE4D | Q08499 | 4/20 | 0.37 |
| ▸ | CCNE2 | O96020 | 1/20 | 0.36 |
| ▸ | CDK4 | P11802 | 1/20 | 0.36 |
| ▸ | CCND1 | P24385 | 1/20 | 0.36 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.36 |
| ▸ | CDK2 | P24941 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6023289 | 0.89 | PDE2A (0.47) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6023837 | 0.87 | PDE2A (0.51) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6024102 | 0.86 | PDE2A (0.47) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6445847 | 0.85 | PDE2A (0.42) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6023204 | 0.84 | PDE2A (0.51) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7354927 | 0.81 | PDE2A (0.57) | PDE2ACCNE2CDK4CCND1CCNE1 | |
| SCHEMBL6023263 | 0.79 | PDE2A (0.44) | PDE2ARNASEH1 | |
| SCHEMBL6024368 | 0.79 | PDE2A (0.46) | PDE2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL4947310 | 0.78 | PDE2A (0.62) | PDE2ACCNE2CDK4CCND1CCNE1 | |
| SCHEMBL6023710 | 0.78 | PDE2A (0.47) | PDE2ACCNE2CDK4CCND1CCNE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060106037-A1 | Purin-6-one-derivatives | ALTANA PHARMA AG (DE) | 2006-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060106037-A1 | Purin-6-one-derivatives | PDE4B, PDE4A, PDE2A | PDE2A 3/4885PDE4A 2/4885PDE4B 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.